Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1558-1570
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1558
Table 1 Baseline characteristics, n (%)
ItemBefore matching

P valueAfter matching

P value
RALAR, n = 125
LALAR, n = 279
RALAR, n = 111
LALAR, n = 111
Gender0.8710.8961
Male76 (60.8)172 (61.6)67 (60.4)65 (58.6)
Female49 (39.2)107 (38.4)44 (39.6)46 (41.4)
Age (yr)62 (55-68)63 (54-68)0.95762 (55-66)61 (53-68)0.761
Preoperative hemoglobin (g/L)135.0 (123.5-143.5)134.0 (123.0-145.0)0.593131.7 ± 15.7133.1 ± 17.50.510
Preoperative albumin (g/L)39.5 ± 3.039.1 ± 3.20.24639.4 ± 3.039.8 ± 3.30.430
Preoperative intestinal obstruction8 (6.4)44 (15.8)0.0098 (7.2)7 (6.3)1.0001
Comorbidity
Cardiovascular diseases48 (38.4)106 (38.0)0.93844 (39.6)38 (34.2)0.4411
Cerebrovascular disorders11 (8.8)38 (13.6)0.17010 (9.0)10 (9.0)1.0001
Diabetes mellitus16 (12.8)41 (14.7)0.61313 (11.7)12 (10.8)1.0001
Lung diseases43 (34.4)96 (34.4)0.99936 (32.4)38 (34.2)0.8851
Liver diseases9 (7.2)8 (2.9)0.0454 (3.6)5 (4.5)1.0001
Previous abdominal surgery12 (9.6)33 (11.8)0.51111 (9.9)15 (13.5)0.5231
History of smoking47 (37.6)81 (29.0)0.08739 (35.1)36 (32.4)0.7611
Height of tumor from anal verge (cm)10 (8.0-13.5)10 (6.0-10.0)0.00510 (8.0-12.0)10 (8.0-12.0)0.754
Preventive stoma23 (18.4)111 (39.8)0.00022 (19.8)23 (20.7)1.0001
ASA score0.3400.602
I01 (0.4)00
II102 (81.6)214 (76.7)90 (81.1)93 (83.8)
III23 (18.4)64 (22.9)21 (18.9)18 (16.2)
Classification of NYHA heart function0.8370.893
I77 (61.6)170 (60.9)67 (60.4)68 (61.3)
II48 (38.4)106 (38.0)44 (39.6)43 (38.7)
III03 (1.1)00
BMI (kg/m2)24.2 (22.8-25.9)24.2 (22.1-26.7)0.78024.5 ± 2.824.6 ± 3.50.795
Differentiation0.0530.317
Low3 (2.4)37 (13.3)3 (2.7)4 (3.6)
Medium114 (91.2)218 (78.1)102 (91.9)95 (85.6)
High8 (6.4)24 (8.6)6 (5.4)12 (10.8)
Maximum tumor diameter (cm)4 (3.0-5.0)4 (3.5-5.0)0.1284 (3.0-5.0)4 (3.0-5.0)0.693
Pathological T stage0.6930.925
Tis02 (0.7)02 (1.8)
110 (8.0)15 (5.4)9 (8.1)7 (6.3)
234 (27.2)70 (25.1)32 (28.8)26 (23.4)
374 (59.2)185 (66.3)64 (57.7)74 (66.7)
4a7 (5.6)7 (2.5)6 (5.4)2 (1.8)
Pathological N stage0.0460.534
080 (64.0)154 (55.2)69 (62.2)72 (64.9)
1a19 (15.2)38 (13.6)18 (16.2)17 (15.3)
1b13 (10.4)38 (13.6)12 (10.8)12 (10.8)
1c07 (2.5)02 (1.8)
2a8 (6.4)19 (6.8)8 (7.2)6 (5.4)
2b5 (4.0)23 (8.2)4 (3.6)2 (1.8)
Pathological TNM stage0.1400.712
002 (0.7)02 (1.8)
I34 (27.2)69 (24.7)31 (27.9)28 (25.2)
IIA43 (34.4)81 (29.0)36 (32.4)41 (36.9)
IIB3 (2.4)2 (0.7)2 (1.8)1 (0.9)
IIIA9 (7.2)15 (5.4)9 (8.1)5 (4.5)
IIIB30 (24.0)85 (30.5)28 (25.2)31 (27.9)
IIIC6 (4.8)25 (9.0)5 (4.5)3 (2.7)